These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 36463105)

  • 21. Comparative review of the carbapenems.
    Zhanel GG; Wiebe R; Dilay L; Thomson K; Rubinstein E; Hoban DJ; Noreddin AM; Karlowsky JA
    Drugs; 2007; 67(7):1027-52. PubMed ID: 17488146
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure-based functional fitness analyses of carbapenemase variants identified among pathogenic carbapenem-resistant Gram-negative bacteria.
    Pal A; Bhattacharyya I; Tripathi A
    World J Microbiol Biotechnol; 2020 Jul; 36(9):129. PubMed ID: 32712930
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heteroresistance to colistin in oxacillinase-producing carbapenem-resistant Acinetobacter baumannii clinical isolates from Gorgan, Northern Iran.
    Ezadi F; Jamali A; Heidari A; Javid N; Ardebili A
    J Glob Antimicrob Resist; 2020 Jun; 21():380-385. PubMed ID: 31770604
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activities of doripenem against nosocomial bacteremic drug-resistant Gram-negative bacteria in a medical center in Taiwan.
    Dong SX; Wang JT; Chang SC
    J Microbiol Immunol Infect; 2012 Dec; 45(6):459-64. PubMed ID: 23102796
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Five novel carbapenem-hydrolysing OXA-type β-lactamase groups are intrinsic in Acinetobacter spp.
    Tian J; Zhang G; Ju Y; Tang N; Li J; Jia R; Feng J
    J Antimicrob Chemother; 2018 Dec; 73(12):3279-3284. PubMed ID: 30247543
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro activity of colistin against multidrug-resistant Acinetobacter baumannii isolates harboring blaOXA-23-like and blaOXA-24-like genes: A multicenter based study.
    Khanjani S; Sedigh Ebrahim-Saraie H; Shenagari M; Ashraf A; Mojtahedi A; Atrkar Roushan Z
    Acta Microbiol Immunol Hung; 2020 Mar; 67(3):182-186. PubMed ID: 32160785
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Comparative evaluation of in vitro activities of carbapenems against gram-negative pathogens: Turkish data of COMPACT study].
    Korten V; Söyletir G; Yalçın AN; Oğünç D; Dokuzoğuz B; Esener H; Ulusoy S; Tünger A; Aygen B; Sümerkan B; Arman D; Dizbay M; Akova M; Hasçelik G; Eraksoy H; Başaran S; Köksal I; Bayramoğlu G; Akalın H; Sınırtaş M
    Mikrobiyol Bul; 2011 Apr; 45(2):197-209. PubMed ID: 21644063
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular mechanisms associated with nosocomial carbapenem-resistant Acinetobacter baumannii in Mexico.
    Alcántar-Curiel MD; García-Torres LF; González-Chávez MI; Morfín-Otero R; Gayosso-Vázquez C; Jarillo-Quijada MD; Fernández-Vázquez JL; Giono-Cerezo S; Rodríguez-Noriega E; Santos-Preciado JI
    Arch Med Res; 2014 Oct; 45(7):553-60. PubMed ID: 25450581
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A prospective multicenter study on the evaluation of antimicrobial resistance and molecular epidemiology of multidrug-resistant Acinetobacter baumannii infections in intensive care units with clinical and environmental features.
    Boral B; Unaldi Ö; Ergin A; Durmaz R; Eser ÖK;
    Ann Clin Microbiol Antimicrob; 2019 Jul; 18(1):19. PubMed ID: 31266519
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transition of blaOXA-58-like to blaOXA-23-like in Acinetobacter baumannii Clinical Isolates in Southern China: An 8-Year Study.
    Wu W; He Y; Lu J; Lu Y; Wu J; Liu Y
    PLoS One; 2015; 10(9):e0137174. PubMed ID: 26340666
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacodynamic profiling of doripenem, imipenem and meropenem against prevalent Gram-negative organisms in the Asia-Pacific region.
    Kiratisin P; Keel RA; Nicolau DP
    Int J Antimicrob Agents; 2013 Jan; 41(1):47-51. PubMed ID: 23127484
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Investigation of oxacillinase genes in nosocomial multidrug-resistant Acinetobacter baumannii isolates by multiplex PCR and evaluation of their clonal relationship with Rep-PCR].
    Sarı B; Baran I; Alaçam S; Mumcuoğlu İ; Kurşun Ş; Aksu N
    Mikrobiyol Bul; 2015 Apr; 49(2):249-58. PubMed ID: 26167825
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phenotypic and genotypic characterization of carbapenem-resistant
    Abouelfetouh A; Torky AS; Aboulmagd E
    Antimicrob Resist Infect Control; 2019; 8():185. PubMed ID: 31832185
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular epidemiology and antimicrobial resistance phenotypes of Acinetobacter baumannii isolated from patients in three hospitals in southern Vietnam.
    Tuan Anh N; Nga TVT; Tuan HM; Tuan NS; Y DM; Vinh Chau NV; Baker S; Duong HHT
    J Med Microbiol; 2017 Jan; 66(1):46-53. PubMed ID: 28198682
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Distribution of extended spectrum beta-lactamase resistance genes among nosocomial imipenem resistant A. Baumannii strains harboring BLAoxa-23 carbapenemases isolated from Ilam and Tehran.
    Taherikalani M; Sekawi Z; Azizi-Jalilian F; Keshavarz B; Soroush S; Akbari M; Emaneini M; Asadollahi P; Maleki MH; Mohammadi S; Pakzad I; Delpisheh A; Asadollahi K
    J Biol Regul Homeost Agents; 2013; 27(3):883-9. PubMed ID: 24152853
    [TBL] [Abstract][Full Text] [Related]  

  • 36. blaOXA-23-like and blaTEM rather than blaOXA-51-like contributed to a high level of carbapenem resistance in Acinetobacter baumannii strains from a teaching hospital in Xi'an, China.
    Han L; Lei J; Xu J; Han S
    Medicine (Baltimore); 2017 Dec; 96(48):e8965. PubMed ID: 29310399
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Antimicrobial susceptibility and molecular characterization of multidrug-resistant Acinetobacter baumannii isolated in an university hospital].
    Direkel Ş; Çopur Çiçek A; Karagöz A; Aydoğan Ejder N; Oktay E; Delialioğlu N; Özgümüş OB; Durmaz R
    Mikrobiyol Bul; 2016 Oct; 50(4):522-534. PubMed ID: 28124957
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    Soudeiha MAH; Dahdouh EA; Azar E; Sarkis DK; Daoud Z
    Front Cell Infect Microbiol; 2017; 7():209. PubMed ID: 28596943
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Imipenem, meropenem, or doripenem to treat patients with Pseudomonas aeruginosa ventilator-associated pneumonia.
    Luyt CE; Aubry A; Lu Q; Micaelo M; Bréchot N; Brossier F; Brisson H; Rouby JJ; Trouillet JL; Combes A; Jarlier V; Chastre J
    Antimicrob Agents Chemother; 2014; 58(3):1372-80. PubMed ID: 24342638
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro sensitivity of Acinetobacter baumannii and Pseudomonas aeruginosa to carbapenems among intensive care unit patients.
    Guzek A; Korzeniewski K; Nitsch-Osuch A; Rybicki Z; Prokop E
    Adv Exp Med Biol; 2013; 788():109-16. PubMed ID: 23835967
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.